46 patients primary malignant glioma cohort in Chinese population
|Study ID||Alternative Stable ID||Type|
We recruited 46 Chinese patients with primary malignant glioma. All the patients were analyzed with whole-exome sequencing (WES) and 27 of them were analyzed with RNA-seq. We compared the molecular features between patients in different WHO grades. We used six-month progression-free survival (PFS6) status to group glioblastoma (GBM) patients to a good and a poor survival compared two groups genomic profiles.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
the source data in VCF format of 46 patients primary malignant glioma cohort in Chinese population
Who archives the data?